India to United States: Budesonide Export Trade Route
India has recorded 479 verified shipments of Budesonide exported to United States, representing a combined trade value of $91.3M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $190.7K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 92% of total export value with 327 shipments worth $83.8M USD. On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer in United States with $74.7M USD in purchases. The top 3 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Budesonide corridor is one of India's established pharmaceutical export routes, with 479 shipments documented worth a combined $91.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's budesonide manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $190.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with budesonide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 15.4%, placing it at rank #6 among India's top budesonide export destinations globally.
On the import side, key buyers of Indian budesonide in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, EXELAN PHARMACEUTICALS, INC and 26 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 260 shipments valued at $74.7M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#6
- Annual growth+15.4%
- Demand growth+15.3%
- Regulatory ease86/100
Top 10 Indian Budesonide Exporters to United States
Showing top 10 of 12 Indian suppliers exporting Budesonide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $256.2K per shipment | 327 | $83.8M | 91.7% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $47.7K per shipment | 119 | $5.7M | 6.2% |
| 3 | ZYDUS LIFESCIENCES LIMITED Avg $168.5K per shipment | 7 | $1.2M | 1.3% |
| 4 | CADILA HEALTHCARE LIMITED Avg $111.1K per shipment | 5 | $555.7K | 0.6% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $24.1K per shipment | 4 | $96.4K | 0.1% |
| 6 | EUGIA PHARMA SPECIALITIES LIMITED Avg $11.8K per shipment | 3 | $35.3K | 0.0% |
| 7 | HEALING PHARMA INDIA PRIVATE LIMITED Avg $563 per shipment | 1 | $563 | 0.0% |
| 8 | VEA IMPEX (I) PRIVATE LIMITED Avg $50 per shipment | 8 | $404 | 0.0% |
| 9 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $72 per shipment | 2 | $145 | 0.0% |
| 10 | AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED Avg $113 per shipment | 1 | $113 | 0.0% |
This table shows the top 10 of 12 Indian companies exporting budesonide to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, EUGIA PHARMA SPECIALITIES LIMITED, HEALING PHARMA INDIA PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED. CIPLA LIMITED is the dominant supplier with 327 shipments worth $83.8M USD, giving it a 92% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to United States Budesonide export route.
Top 10 Budesonide Importers in United States
Showing top 10 of 29 known buyers in United States receiving Budesonide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian budesonide in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, EXELAN PHARMACEUTICALS, INC, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, among 29 total buyers. The largest importer is CIPLA USA INC UPS SUPPLY CHAIN SOLU, accounting for $74.7M USD across 260 shipments — representing 82% of all budesonide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 260 | $74.7M | 81.8% |
| 2 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 26 | $4.6M | 5.0% |
| 3 | EXELAN PHARMACEUTICALS, INC | 13 | $3.6M | 4.0% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 37 | $3.0M | 3.3% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES INC | 42 | $1.5M | 1.6% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES,INC.. | 16 | $965.3K | 1.1% |
| 7 | XXDUSXXHARXXCEUXXCALXXUSAXXNC | 3 | $702.4K | 0.8% |
| 8 | EXELAN PHARMACEUTICALS INC | 16 | $580.8K | 0.6% |
| 9 | XXRTHXXAR XXALTXXAREXXNLIXXTEDXXOMPX | 4 | $477.1K | 0.5% |
| 10 | NORTHSTAR HEALTHCARE UNLIMITED COMP | 3 | $311.5K | 0.3% |
Showing top 10 of 29 Budesonide importers in United States on this route.
Top 10 Budesonide Formulations Imported by United States
Showing top 10 of 228 product formulations shipped on the India to United States Budesonide route, ranked by trade value
United States imports a wide range of budesonide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BUDESONIDE INHALATION SUSPENSION 1MG/2ML; NDC NO. 69097-321-87; ANDA NO. 205710PACK SIZE 6 X 5 X 2 ML — accounts for $9.1M USD across 2 shipments. There are 228 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BUDESONIDE INHALATION SUSPENSION 1MG/2ML; NDC NO. 69097-321-87; ANDA NO. 205710PACK SIZE 6 X 5 X 2 ML | 2 | $9.1M | 9.9% |
| 2 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML; NDC NO. 69097-319-87; ANDA NO. 205710 PACK SIZE 6 X 5 X 2 ML | 13 | $5.7M | 6.3% |
| 3 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 (6 X 5 X 2 ML) (13896 PACKS X 6X5S=41 | 4 | $4.2M | 4.6% |
| 4 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 (6 X 5 X 2 ML) (13728 PACKS X 6X5S=41 | 2 | $4.2M | 4.6% |
| 5 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 (6 X 5 X 2 ML) (13872 PACKS X 6X5S=41 | 1 | $4.1M | 4.5% |
| 6 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 (6 X 5 X 2 ML) (13824 PACKS X 6X5S=41 | 1 | $4.1M | 4.5% |
| 7 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 (6 X 5 X 2 ML) (13464 PACKS X 6X5S=40 | 2 | $4.1M | 4.5% |
| 8 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML; NDC NO.69097-319-87;ANDA NO.205710 [PAC SIZE:6X5X2 MLX13776 PAC=413280 NOS] | 1 | $4.1M | 4.4% |
| 9 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML NDC NO. 69097-319-87 ANDA NO. 205710 (6 X 5 X 2 ML) (13560 PACKS X 6X5S=4 | 1 | $4.0M | 4.4% |
| 10 | BUDESONIDE INHALATION SUSPENSION 0.5MG/2ML, NDC NO. 7628264138; ANDA NO. : 205710 PACK SIZE 6 X 5 X 2 ML | 2 | $3.3M | 3.6% |
Showing top 10 of 228 Budesonide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 206 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's budesonide exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 327 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED — together account for 99% of total trade value on this route. The average shipment value of $190.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as budesonide inhalation suspension 0.5mg/2ml; ndc no. 69097-319-87; anda no. 205710 pack size 6 x 5 x 2 ml and budesonide inhalation suspension 0.5mg/2ml ndc no. 69097-319-87 anda no. 205710 (6 x 5 x 2 ml) (13896 packs x 6x5s=41, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 260 shipments worth $74.7M USD — representing 82% of all budesonide imports from India on this route. A total of 29 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $91.3M
- Avg. Shipment
- $190.7K
- Suppliers
- 12
- Buyers
- 29
- Transit (Sea)
- ~27 days
- Annual Growth
- +15.4%
Related Analysis
Reverse Direction
United States → India — Budesonide (Import)Other Budesonide Routes
Unlock the Full India to United States Budesonide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 479 shipments on this route.
Frequently Asked Questions — India to United States Budesonide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Budesonide to United States?
The leading Indian exporters of Budesonide to United States are CIPLA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED. CIPLA LIMITED holds the largest market share at approximately 92% of total trade value on this route.
Q What is the total value of Budesonide exports from India to United States?
India exports Budesonide to United States worth approximately $91.3M USD across 479 recorded shipments. The average value per shipment is $190.7K USD.
Q Which ports does India use to ship Budesonide to United States?
The most active port of origin is SAHAR AIR with 206 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to United States for Budesonide?
The average transit time for Budesonide shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Budesonide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.4% with demand growth tracking at 15.3%. The route is ranked #6 among India's top Budesonide export destinations globally.
Q How many suppliers are active on the India to United States Budesonide route?
There are currently 12 active Indian suppliers exporting Budesonide to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 92% of total shipment value.
Q Who are the main importers of Budesonide from India in United States?
The leading importers of Indian Budesonide in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, EXELAN PHARMACEUTICALS, INC, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer with 260 shipments worth $74.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Budesonide.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 29 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 479 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
479 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists